Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Percent of time spent in each pain state over 48-h

From: Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial

 

Complete case analysis

Pain states

Zav (n = 327)

PBO (n = 303)

Mean difference

None

75%

69%

 + 6%

Mild

16%

20%

 − 4%

Moderate

7%

9%

 − 2%

Severe

2%

2%

0%

 

MNAR imputation analysis

Pain states

Zav (n= 623)

PBO (n = 646)

Mean difference

None

56%

48%

 + 8%

Mild

21%

23%

 − 2%

Moderate

18%

23%

 − 5%

Severe

5%

6%

 − 1%

  1. Abbreviations: MNAR missing not at random, PBO placebo, zav zavegepant
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us